Federated Hermes
TFFP

Federated Hermes’s TFF Pharmaceuticals, Inc. Common Stock TFFP Stock Holding History

Federated Hermes’s Portfolio TFFP Stock Details TFFP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-9
Closed -$4K – 2357
2020
Q3 		$4K Buy
+9
New +$2.54K ﹤0.01% 2059

Other funds holding TFFP

NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
CA
Corriente Advisors Fort Worth, Texas $9.53M AUM 805.26% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Hudson Bay Capital Management
Hudson Bay Capital Management Stamford, Connecticut $29B AUM 30.2% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
GS
Gagnon Securities New York $433M AUM 29.08% 1-Year Est. Return
UOTTAIMCU
University of Texas/Texas AM Investment Management Co (UTIMCO) Austin, Texas $687M AUM 21.33% 1-Year Est. Return
GA
Gagnon Advisors New York $136M AUM 21.55% 1-Year Est. Return
PM
Precept Management Dallas, Texas $126M AUM 36.77% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return

Federated Hermes's TFFP Position: Q4 2020 in Review

Federated Hermes sold out of TFF Pharmaceuticals, Inc. Common Stock (TFFP) in Q4 2020, closing a stake of 9 shares — an estimated $4K sold.

Federated Hermes first reported a position in TFFP in Q3 2020 and held it in 1 quarter. The position peaked at $4K in Q3 2020. 47 funds tracked by Wall St. Rank hold TFFP as of Q4 2020.

  • Federated Hermes reported no remaining TFF Pharmaceuticals, Inc. Common Stock position as of Q4 2020 after selling out during the quarter.
  • Federated Hermes sold 9 TFF Pharmaceuticals, Inc. Common Stock shares in Q4 2020, an estimated $4K.
  • Federated Hermes first reported a position in TFF Pharmaceuticals, Inc. Common Stock in Q3 2020 and held it in 1 quarter.
  • Federated Hermes's TFF Pharmaceuticals, Inc. Common Stock position peaked at $4K in Q3 2020.
  • 47 funds tracked by Wall St. Rank held TFF Pharmaceuticals, Inc. Common Stock as of Q4 2020.

Based on Federated Hermes's 13F filing for Q4 2020, filed 12 Feb 2021.